Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.37
+0.31 (0.77%)
Jun 29, 2026, 9:47 AM EDT - Market open
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,277,107
Market Cap
1.93B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 600 |
| Lakefront Biotherapeutics NV | 558 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| Viridian Therapeutics | 252 |
| Monte Rosa Therapeutics | 187 |
| AtaiBeckley | 99 |
RAPP News
- 5 days ago - Rapport Therapeutics initiated with an Outperform at Leerink - TheFly
- 12 days ago - Rapport Therapeutics management to meet with Citizens - TheFly
- 18 days ago - Rapport Therapeutics Transcript: AGM 2026 - Transcripts
- 20 days ago - Rapport Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Rapport Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Rapport Therapeutics price target raised to $65 from $53 at BTIG - TheFly
- 5 weeks ago - Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Rapport Therapeutics assumed with a Buy at Truist - TheFly